Volume -10 | Issue -2
Volume -10 | Issue -2
Volume -10 | Issue -2
Volume -10 | Issue -2
Volume -10 | Issue -2
Multi drug resistant Escherichia coli and Klebsiella pneumoniae expressing extended spectrum β lactamase enzymes (ESBLs) has become a serious challenge to clinicians for the therapeutic management of clinical cases in urinary tract infection. The main objective of the study was focused to determine the dominance of MDR E. coli and Klebsiella pneumoniae and the evaluation of status of β-lactamase enzyme produced by them.